Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
Mesoblast shares fell -4.45% in the first hour of trades on Tuesday as the company announced it has to resubmit an application to the FDA.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
PBA | Ann: Removal from Official List | 25/11/09 | 0 | 457 | |||
|
|||||||
PBA | Ann: Completion of Compulsory Acquisition of Shar | 23/11/09 | 0 | 431 | |||
|
|||||||
PBA | Ann: Part Completion of Compulsory Acquisition of | 04/11/09 | 0 | 432 | |||
|
|||||||
PBA | Ann: Annual Report | 02/11/09 | 0 | 1.2K | |||
|
|||||||
PBA | Ann: Annual General Meeting Proxy Form | 02/11/09 | 0 | 402 | |||
|
|||||||
PBA | Ann: Notice of Annual General Meeting | 02/11/09 | 0 | 310 | |||
|
|||||||
PBA | take over payment | 27/10/09 | 0 | 319 | |||
|
|||||||
PBA | Ann: Final Director's Interest Notice | 23/10/09 | 0 | 344 | |||
|
See All Discussions